Review



human bladder transitional cell carcinoma tcc cell lines j82  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC human bladder transitional cell carcinoma tcc cell lines j82
    Human Bladder Transitional Cell Carcinoma Tcc Cell Lines J82, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 875 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bladder transitional cell carcinoma tcc cell lines j82/product/ATCC
    Average 96 stars, based on 875 article reviews
    human bladder transitional cell carcinoma tcc cell lines j82 - by Bioz Stars, 2026-04
    96/100 stars

    Images



    Similar Products

    96
    ATCC human bladder transitional cell carcinoma tcc cell lines j82
    Human Bladder Transitional Cell Carcinoma Tcc Cell Lines J82, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bladder transitional cell carcinoma tcc cell lines j82/product/ATCC
    Average 96 stars, based on 1 article reviews
    human bladder transitional cell carcinoma tcc cell lines j82 - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    94
    ATCC human bladder carcinoma cell lines
    MSSV-mediated inhibition of proliferation of the <t>human</t> <t>bladder</t> cancer <t>cell</t> <t>lines,</t> 5637 and T24, was owing to G1-phase cell cycle arrest. ( A ) Both cell lines were treated with or without MSSV at the indicated concentrations for 24 h, followed by MTT assays for cell viability. ( B ) Cells were treated with indicated concentrations of MSSV for 24 h, and cell counting was performed via trypan blue staining. ( C ) Both cell lines were treated with MSSV for 24 h and analyzed for cell cycle distribution using fluorescence-activated cell sorting (FACS) histograms. The percentage of cells in each cell cycle phase is presented. ( D ) Cells were exposed to MSSV at the indicated concentrations for 24 h. The expression levels of cyclin D1, cyclin E, CDK2, CDK4, p21WAF1, p27KIP1, p53, and GAPDH were analyzed via immunoblotting. Bar graphs show the relative fold changes in proteins at different MSSV concentrations in comparison with the control. ( E ) The cell lysates were immunoprecipitated with antibodies recognizing CDK2 and CDK4, followed by immunoblotting with specific antibodies against p21WAF1, p27KIP1, CDK2, and CDK4. Graphs show the relative amount of immunoprecipitated proteins as fold changes in comparison with the control. For the bar graphs, values were presented as the mean ± SD of three independent experiments; * p < 0.05, compared with the control group. Uncropped Western Blot Images in .
    Human Bladder Carcinoma Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bladder carcinoma cell lines/product/ATCC
    Average 94 stars, based on 1 article reviews
    human bladder carcinoma cell lines - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    96
    ATCC human urinary bladder transitional cell carcinoma tcc cell lines j82
    MSSV-mediated inhibition of proliferation of the <t>human</t> <t>bladder</t> cancer <t>cell</t> <t>lines,</t> 5637 and T24, was owing to G1-phase cell cycle arrest. ( A ) Both cell lines were treated with or without MSSV at the indicated concentrations for 24 h, followed by MTT assays for cell viability. ( B ) Cells were treated with indicated concentrations of MSSV for 24 h, and cell counting was performed via trypan blue staining. ( C ) Both cell lines were treated with MSSV for 24 h and analyzed for cell cycle distribution using fluorescence-activated cell sorting (FACS) histograms. The percentage of cells in each cell cycle phase is presented. ( D ) Cells were exposed to MSSV at the indicated concentrations for 24 h. The expression levels of cyclin D1, cyclin E, CDK2, CDK4, p21WAF1, p27KIP1, p53, and GAPDH were analyzed via immunoblotting. Bar graphs show the relative fold changes in proteins at different MSSV concentrations in comparison with the control. ( E ) The cell lysates were immunoprecipitated with antibodies recognizing CDK2 and CDK4, followed by immunoblotting with specific antibodies against p21WAF1, p27KIP1, CDK2, and CDK4. Graphs show the relative amount of immunoprecipitated proteins as fold changes in comparison with the control. For the bar graphs, values were presented as the mean ± SD of three independent experiments; * p < 0.05, compared with the control group. Uncropped Western Blot Images in .
    Human Urinary Bladder Transitional Cell Carcinoma Tcc Cell Lines J82, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human urinary bladder transitional cell carcinoma tcc cell lines j82/product/ATCC
    Average 96 stars, based on 1 article reviews
    human urinary bladder transitional cell carcinoma tcc cell lines j82 - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    96
    ATCC human urinary bladder transitional cell carcinoma cell lines j82
    MSSV-mediated inhibition of proliferation of the <t>human</t> <t>bladder</t> cancer <t>cell</t> <t>lines,</t> 5637 and T24, was owing to G1-phase cell cycle arrest. ( A ) Both cell lines were treated with or without MSSV at the indicated concentrations for 24 h, followed by MTT assays for cell viability. ( B ) Cells were treated with indicated concentrations of MSSV for 24 h, and cell counting was performed via trypan blue staining. ( C ) Both cell lines were treated with MSSV for 24 h and analyzed for cell cycle distribution using fluorescence-activated cell sorting (FACS) histograms. The percentage of cells in each cell cycle phase is presented. ( D ) Cells were exposed to MSSV at the indicated concentrations for 24 h. The expression levels of cyclin D1, cyclin E, CDK2, CDK4, p21WAF1, p27KIP1, p53, and GAPDH were analyzed via immunoblotting. Bar graphs show the relative fold changes in proteins at different MSSV concentrations in comparison with the control. ( E ) The cell lysates were immunoprecipitated with antibodies recognizing CDK2 and CDK4, followed by immunoblotting with specific antibodies against p21WAF1, p27KIP1, CDK2, and CDK4. Graphs show the relative amount of immunoprecipitated proteins as fold changes in comparison with the control. For the bar graphs, values were presented as the mean ± SD of three independent experiments; * p < 0.05, compared with the control group. Uncropped Western Blot Images in .
    Human Urinary Bladder Transitional Cell Carcinoma Cell Lines J82, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human urinary bladder transitional cell carcinoma cell lines j82/product/ATCC
    Average 96 stars, based on 1 article reviews
    human urinary bladder transitional cell carcinoma cell lines j82 - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    96
    ATCC human bladder carcinoma cell lines j82
    MSSV-mediated inhibition of proliferation of the <t>human</t> <t>bladder</t> cancer <t>cell</t> <t>lines,</t> 5637 and T24, was owing to G1-phase cell cycle arrest. ( A ) Both cell lines were treated with or without MSSV at the indicated concentrations for 24 h, followed by MTT assays for cell viability. ( B ) Cells were treated with indicated concentrations of MSSV for 24 h, and cell counting was performed via trypan blue staining. ( C ) Both cell lines were treated with MSSV for 24 h and analyzed for cell cycle distribution using fluorescence-activated cell sorting (FACS) histograms. The percentage of cells in each cell cycle phase is presented. ( D ) Cells were exposed to MSSV at the indicated concentrations for 24 h. The expression levels of cyclin D1, cyclin E, CDK2, CDK4, p21WAF1, p27KIP1, p53, and GAPDH were analyzed via immunoblotting. Bar graphs show the relative fold changes in proteins at different MSSV concentrations in comparison with the control. ( E ) The cell lysates were immunoprecipitated with antibodies recognizing CDK2 and CDK4, followed by immunoblotting with specific antibodies against p21WAF1, p27KIP1, CDK2, and CDK4. Graphs show the relative amount of immunoprecipitated proteins as fold changes in comparison with the control. For the bar graphs, values were presented as the mean ± SD of three independent experiments; * p < 0.05, compared with the control group. Uncropped Western Blot Images in .
    Human Bladder Carcinoma Cell Lines J82, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bladder carcinoma cell lines j82/product/ATCC
    Average 96 stars, based on 1 article reviews
    human bladder carcinoma cell lines j82 - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    94
    ATCC human bladder carcinoma cell line pc 3m
    MSSV-mediated inhibition of proliferation of the <t>human</t> <t>bladder</t> cancer <t>cell</t> <t>lines,</t> 5637 and T24, was owing to G1-phase cell cycle arrest. ( A ) Both cell lines were treated with or without MSSV at the indicated concentrations for 24 h, followed by MTT assays for cell viability. ( B ) Cells were treated with indicated concentrations of MSSV for 24 h, and cell counting was performed via trypan blue staining. ( C ) Both cell lines were treated with MSSV for 24 h and analyzed for cell cycle distribution using fluorescence-activated cell sorting (FACS) histograms. The percentage of cells in each cell cycle phase is presented. ( D ) Cells were exposed to MSSV at the indicated concentrations for 24 h. The expression levels of cyclin D1, cyclin E, CDK2, CDK4, p21WAF1, p27KIP1, p53, and GAPDH were analyzed via immunoblotting. Bar graphs show the relative fold changes in proteins at different MSSV concentrations in comparison with the control. ( E ) The cell lysates were immunoprecipitated with antibodies recognizing CDK2 and CDK4, followed by immunoblotting with specific antibodies against p21WAF1, p27KIP1, CDK2, and CDK4. Graphs show the relative amount of immunoprecipitated proteins as fold changes in comparison with the control. For the bar graphs, values were presented as the mean ± SD of three independent experiments; * p < 0.05, compared with the control group. Uncropped Western Blot Images in .
    Human Bladder Carcinoma Cell Line Pc 3m, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bladder carcinoma cell line pc 3m/product/ATCC
    Average 94 stars, based on 1 article reviews
    human bladder carcinoma cell line pc 3m - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    94
    ATCC ej human bladder carcinoma cell line
    Inhibition of the proliferation of EJ <t>bladder</t> cancer cells by heterometallic Au@Pt-NSs. Notes: Both EJ cells and HUCs were incubated for 24 h with different concentrations of Au@Pt-NSs (0, 0.1, 0.3, and 0.5 μM). <t>Cell</t> viability was measured using the MTT assay in EJ cells ( A ) and HUCs ( D ). Viable cells were measured using trypan blue staining for EJ cells ( B ) and HUCs ( E ). Morphological changes were observed after treatment with Au@Pt-NSs at different concentrations (0, 0.1, 0.3, and 0.5 μM) for EJ cells ( C ) and HUCs ( F ). For the bar graphs, values are presented as mean ± SD of three independent experiments; * P < 0.05, compared with the control group. Abbreviations: Au@Pt-NSs, gold@platinum nanoseeds; Con, negative control; HUCs, <t>human</t> urothelial cells; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
    Ej Human Bladder Carcinoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ej human bladder carcinoma cell line/product/ATCC
    Average 94 stars, based on 1 article reviews
    ej human bladder carcinoma cell line - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    94
    ATCC human bladder carcinoma cell line ej
    Inhibition of the proliferation of EJ <t>bladder</t> cancer cells by heterometallic Au@Pt-NSs. Notes: Both EJ cells and HUCs were incubated for 24 h with different concentrations of Au@Pt-NSs (0, 0.1, 0.3, and 0.5 μM). <t>Cell</t> viability was measured using the MTT assay in EJ cells ( A ) and HUCs ( D ). Viable cells were measured using trypan blue staining for EJ cells ( B ) and HUCs ( E ). Morphological changes were observed after treatment with Au@Pt-NSs at different concentrations (0, 0.1, 0.3, and 0.5 μM) for EJ cells ( C ) and HUCs ( F ). For the bar graphs, values are presented as mean ± SD of three independent experiments; * P < 0.05, compared with the control group. Abbreviations: Au@Pt-NSs, gold@platinum nanoseeds; Con, negative control; HUCs, <t>human</t> urothelial cells; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
    Human Bladder Carcinoma Cell Line Ej, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bladder carcinoma cell line ej/product/ATCC
    Average 94 stars, based on 1 article reviews
    human bladder carcinoma cell line ej - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    Image Search Results


    MSSV-mediated inhibition of proliferation of the human bladder cancer cell lines, 5637 and T24, was owing to G1-phase cell cycle arrest. ( A ) Both cell lines were treated with or without MSSV at the indicated concentrations for 24 h, followed by MTT assays for cell viability. ( B ) Cells were treated with indicated concentrations of MSSV for 24 h, and cell counting was performed via trypan blue staining. ( C ) Both cell lines were treated with MSSV for 24 h and analyzed for cell cycle distribution using fluorescence-activated cell sorting (FACS) histograms. The percentage of cells in each cell cycle phase is presented. ( D ) Cells were exposed to MSSV at the indicated concentrations for 24 h. The expression levels of cyclin D1, cyclin E, CDK2, CDK4, p21WAF1, p27KIP1, p53, and GAPDH were analyzed via immunoblotting. Bar graphs show the relative fold changes in proteins at different MSSV concentrations in comparison with the control. ( E ) The cell lysates were immunoprecipitated with antibodies recognizing CDK2 and CDK4, followed by immunoblotting with specific antibodies against p21WAF1, p27KIP1, CDK2, and CDK4. Graphs show the relative amount of immunoprecipitated proteins as fold changes in comparison with the control. For the bar graphs, values were presented as the mean ± SD of three independent experiments; * p < 0.05, compared with the control group. Uncropped Western Blot Images in .

    Journal: Cancers

    Article Title: A Novel Cyclic Pentadepsipeptide, N -Methylsansalvamide, Suppresses Angiogenic Responses and Exhibits Antitumor Efficacy against Bladder Cancer

    doi: 10.3390/cancers13020191

    Figure Lengend Snippet: MSSV-mediated inhibition of proliferation of the human bladder cancer cell lines, 5637 and T24, was owing to G1-phase cell cycle arrest. ( A ) Both cell lines were treated with or without MSSV at the indicated concentrations for 24 h, followed by MTT assays for cell viability. ( B ) Cells were treated with indicated concentrations of MSSV for 24 h, and cell counting was performed via trypan blue staining. ( C ) Both cell lines were treated with MSSV for 24 h and analyzed for cell cycle distribution using fluorescence-activated cell sorting (FACS) histograms. The percentage of cells in each cell cycle phase is presented. ( D ) Cells were exposed to MSSV at the indicated concentrations for 24 h. The expression levels of cyclin D1, cyclin E, CDK2, CDK4, p21WAF1, p27KIP1, p53, and GAPDH were analyzed via immunoblotting. Bar graphs show the relative fold changes in proteins at different MSSV concentrations in comparison with the control. ( E ) The cell lysates were immunoprecipitated with antibodies recognizing CDK2 and CDK4, followed by immunoblotting with specific antibodies against p21WAF1, p27KIP1, CDK2, and CDK4. Graphs show the relative amount of immunoprecipitated proteins as fold changes in comparison with the control. For the bar graphs, values were presented as the mean ± SD of three independent experiments; * p < 0.05, compared with the control group. Uncropped Western Blot Images in .

    Article Snippet: The human bladder carcinoma cell lines, 5637 and T24, were purchased from the American Type Culture Collection (Manassas, VA, USA) and maintained in Dulbecco’s modified Eagle medium supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin at 37 °C in a 5% CO 2 humidified incubator.

    Techniques: Inhibition, Cell Counting, Staining, Fluorescence, FACS, Expressing, Western Blot, Comparison, Control, Immunoprecipitation

    Inhibition of the proliferation of EJ bladder cancer cells by heterometallic Au@Pt-NSs. Notes: Both EJ cells and HUCs were incubated for 24 h with different concentrations of Au@Pt-NSs (0, 0.1, 0.3, and 0.5 μM). Cell viability was measured using the MTT assay in EJ cells ( A ) and HUCs ( D ). Viable cells were measured using trypan blue staining for EJ cells ( B ) and HUCs ( E ). Morphological changes were observed after treatment with Au@Pt-NSs at different concentrations (0, 0.1, 0.3, and 0.5 μM) for EJ cells ( C ) and HUCs ( F ). For the bar graphs, values are presented as mean ± SD of three independent experiments; * P < 0.05, compared with the control group. Abbreviations: Au@Pt-NSs, gold@platinum nanoseeds; Con, negative control; HUCs, human urothelial cells; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.

    Journal: International Journal of Nanomedicine

    Article Title: Inhibitory effect of Au@Pt-NSs on proliferation, migration, and invasion of EJ bladder carcinoma cells: involvement of cell cycle regulators, signaling pathways, and transcription factor-mediated MMP-9 expression

    doi: 10.2147/IJN.S158463

    Figure Lengend Snippet: Inhibition of the proliferation of EJ bladder cancer cells by heterometallic Au@Pt-NSs. Notes: Both EJ cells and HUCs were incubated for 24 h with different concentrations of Au@Pt-NSs (0, 0.1, 0.3, and 0.5 μM). Cell viability was measured using the MTT assay in EJ cells ( A ) and HUCs ( D ). Viable cells were measured using trypan blue staining for EJ cells ( B ) and HUCs ( E ). Morphological changes were observed after treatment with Au@Pt-NSs at different concentrations (0, 0.1, 0.3, and 0.5 μM) for EJ cells ( C ) and HUCs ( F ). For the bar graphs, values are presented as mean ± SD of three independent experiments; * P < 0.05, compared with the control group. Abbreviations: Au@Pt-NSs, gold@platinum nanoseeds; Con, negative control; HUCs, human urothelial cells; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.

    Article Snippet: The EJ human bladder carcinoma cell line was purchased from American Type Culture Collection (ATCC, Manassas, VA, USA) and maintained in Dulbecco’s Modified Eagle’s Medium supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin at 37°C in a 5% CO 2 humidified incubator.

    Techniques: Inhibition, Incubation, MTT Assay, Staining, Control, Negative Control